Veterinary Medicines

CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS

Authorised
  • Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
Download as PDF

Product identification

Medicine name:
CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
Cevac IBird liofilizāts suspensijas pagatavošanai vistām
Active substance:
  • Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
Target species:
  • Chicken (broiler)
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Oculonasal use
  • Oral use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
    2.80
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/13/0031
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0245/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 23/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."